Transasia Bio-Medicals - Building a healthier future through innovation and affordability :: Transasia Bio-Medicals

Transasia Bio-Medicals - Building a healthier future through innovation and affordability

Transasia Bio-Medicals | Innovative and Affordable IVD Products for a Healthier Future

Medgate Today, May 2022: India’s Leading In-vitro Diagnostic Company Transasia Bio-Medicals is today recognized as a global organization serving over 100 countries. Working relentlessly towards its vision of a Healthier and Happier World, the group continues to be a trusted partner for lab professionals and clinicians in enhancing patient care. What has driven this company that started as a provider of after-sales service to become a global player in the last four decades? Let us dive deep:

The road less traversed

Founder Chairman of the Transasia-Erba Group, Mr. Suresh Vazirani started his journey as a qualified electrical engineer who was in the quest of doing something meaningful for society. A chance encounter made him realize that India was lacking way behind from the West, in terms of medical technology. Moved by the state of affairs, he decided to set up Transasia Bio-Medicals with a mission to meet the needs of Doctors and patients for reliable, quality, and affordable diagnostic solutions.

Transasia started off as a provider of after-sales service for a Japanese equipment company. However, being imported, these analyzers were expensive. A true Indian by heart, Mr. Vazirani set up Transasia’s manufacturing facility to provide Made in India, and high-quality equipment for affordable and accessible diagnostics.

Making in India for an Atmanirbhar Bharat

From one manufacturing facility in the early 1990s, the organization has today strengthened its manufacturing prowess with five state-of-the-art units in India and two in Europe and USA. All these facilities are centres of excellence and compliant with ISO, US FDA, and ICMED. The latest amenity in Vizag facility at the Andhra Pradesh Medtech Zone (AMTZ) was set up during the lockdown and is Asia’s largest for manufacturing tests for COVID and other infectious diseases. All these Made in India products are exported to over 100 countries across the world.

Expanding global footprints

While on one hand, Transasia has cemented its position as India’s Number One IVD Company, another interesting fact, was that it was among the first Indian IVD Companies to receive a CE and US FDA certification for its products to be available in the global markets. What started off as a subsidiary in Germany is today the Transasia-Erba group with a presence in 12 locations, besides serving millions in over 100 countries.

Subsidiaries such as Erba Molecular have made the group as the selected few companies with its own patented technology for molecular testing. Formerly known as Calbiotech, Erba USA offers more than 200 immunoassays specific for human and animal research including specific assays for autoimmune disorders, cancer, and infectious diseases.

Reaching out to emerging markets

Providing reliable, accurate, and affordable diagnostic solutions is the mission of the group. Our R&D facilities in India, Czech Republic, USA, France, UK, and Austria work together to introduce technologically advanced products. These are then customized to meet the needs of the emerging economies.

In fact, Transasia’s fully and semi-automated analyzers for clinical chemistry, hematology, and immunology have been gaining widespread acceptance from countries such as Bangladesh, Philippines, Indonesia, Vietnam, Czech Republic, and many more.

The group offers more than 1,000 types of instruments and test kits to cater to communicable and lifestyle diseases across all segments.

Setting benchmarks as India’s Leading IVD Company

Today, Transasia has an impressive installation base of 70,000 pieces of equipment across 40,000 laboratories in India. Our sales, technical, and application support teams are our biggest strengths that augment our quality product portfolio. In fact, we are proud to have the largest team of over 800 sales and service experts in the Indian IVD Industry that caters to 25 zonal offices and 130+ service locations in India (the highest in the Indian IVD Industry). We are also strengthening our channel partner network to cater to every part of the country.

Our teams reach out to some of the most remote and treacherous regions of the country not serviced by any other company!

Quality, affordability, and accessibility have made us the preferred choice for several large public procurement projects for the state and central government institutes.

Giving back to society its due

The Transasia-Erba group works with communities to build a world of hope and happiness. For over a decade, we have been associated with PATUT (Parents Association Thalassemic Unit Trust), to aid in the early detection and screening of genetic disorders such as thalassemia. Besides, this we have been running scholarship programs for deserving students who aspire to pursue professional courses.

The Erba Institute of Lab Technology, Panchgani, Maharashtra has been set up to provide opportunities for skill development and livelihood opportunities for people of the nearby areas. With every passing year, the initiative is generating a pool of skilled lab technicians to run diagnostic centres efficiently in the nearby remote areas.

The road ahead

In addition to launching new and advanced diagnostic systems in CLIA, Molecular, high-end hematology, AI, LIS, etc., we will soon be launching a very innovative and affordable ‘Total Solutions in Laboratory Diagnostics.’

2022 will be a landmark year for the Transasia-Erba group in which it will be launching many of these hi-tech solutions that will enhance clinical outcomes for a Healthy and Happy World.